Sanofi Adr Stock Widgets and Gadgets
| SNY Stock | USD 49.46 0.57 1.14% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- SNY Sanofi ADR
- Latest Earnings call 10x Genomics posts 5 percent revenue growth in Q1 2024
- SNY 49.46 -0.57
- Low 48.27
- High 49.47
- Volume 4.6 M
- Alpha -0.0341
- Beta 0.2
- Return On Equity 0.0727
- Return On Asset 0.0454
- Profit Margin 0.1 %
- Operating Margin 0.18 %
- Current Valuation 72.49 B
- Shares Outstanding 2.5 B
- Shares Owned By Institutions 10.06 %
- Number Of Shares Shorted 3.24 M
- Price To Earning 7.78 X
- Price To Book 1.44 X
- Price To Sales 2.52 X
- Revenue 43.07 B
- Gross Profit 31.7 B
- EBITDA 12.96 B
- Net Income 5.4 B
- Cash And Equivalents 6.9 B
- Cash Per Share 2.76 X
- Total Debt 18.42 B
- Debt To Equity 0.30 %
- Current Ratio 1.30 X
- Book Value Per Share 59.17 X
- Cash Flow From Operations 10.26 B
- Short Ratio 1.71 X
- Earnings Per Share 1.94 X
- Price To Earnings To Growth 0.84 X
- Target Price 58.92
- Number Of Employees 86.09 K
- Beta 0.45
- Market Capitalization 124.9 B
- Total Asset 126.46 B
- Retained Earnings 67.5 B
- Working Capital 6.46 B
- Current Asset 24.93 B
- Current Liabilities 16.82 B
- Annual Yield 0.04 %
- Five Year Return 3.85 %
- Net Asset 126.46 B
- Accumulation Distribution 111501.0
- Daily Balance Of Power (0.47)
- Rate Of Daily Change 0.99
- Day Median Price 48.87
- Day Typical Price 49.07
- Price Action Indicator 0.3
- Period Momentum Indicator (0.57)
- Relative Strength Index 32.91
Market Snapshot Widget Example
DAX Index Germany | 17,896 0.2 | |
Taiwan Weighted Taiwan | 20,222 0.85 | |
PSI 20 Stock Portugal | 6,665 0.75 | |
CROBEX Croatia | 2,813 0.23 | |
Budapest SE Hungary | 68,124 0.03 | |
IDX 30 Jakarta Indonesia | 455.63 3.19 | |
ISEQ 20 Price Ireland | 1,648 0.34 | |
NYSE Comp USA | 17,699 0.70 | |
Tel Aviv 35 Israel | 1,939 0.46 | |
Coreshares Index Tracker South Afric | 1,046 0.1 | |
IPC MEXICO Mexico | 56,677 0.09 | |
KL Technology Malaysia | 64.77 0.6 | |
IBEX 35 Index Spain | 10,872 0.16 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,590 0.84 | |
SPASX Dividend Opportunities Australia | 1,634 0.01 | |
HNX 30 Vietnam | 488.22 0.53 | |
Bucharest BET-NG Romania | 1,223 0.09 | |
AMS Small Cap Netherlands | 1,172 1.51 | |
Oslo Exchange Mutual Norway | 1,315 0.59 | |
BEL Small Belgium | 9,013 0.13 | |
RTSI Index Russia | 1,177 0.22 | |
Basic Materials Brazil | 5,784 1.40 | |
Swiss Leader Price Switzerland | 1,833 0.35 | |
Fondo Mutuo ETF Chile | 1,426 0.11 | |
Athens General Comp Greece | 1,452 0.26 | |
Stock Exchange Of Thailand | 1,363 0.34 | |
PX Prague Stock Czech Repub | 1,549 0.12 | |
THE PHILIPPINE STOCK Philippines | 6,647 0.81 | |
WIG 30 Poland | 3,063 0.24 | |
BIST Electricity Turkey | 609.75 2.74 |
Investing Ideas
In addition to having Sanofi ADR in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Sanofi ADR
Compare Sanofi ADR To Peers
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Sanofi Stock analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 1.94 | Revenue Per Share 18.492 | Quarterly Revenue Growth 0.023 | Return On Assets 0.0454 |
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.